Clinical Trial Update: Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vasopressin to reduce the risk of acute kidney injury in ICU patients with critical illness; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Kidney Injury

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Hospital do Coracao | Conditions: Critical Illness | Phase 2 | Status: RECRUITING